Autism Spectrum Disorder Trial, Recruiting NCT06334588 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06334588
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people diagnosed with or suspected of having autism spectrum disorder (ASD):

  • You are between 3 months and 25 years old
  • You are already scheduled to have an MRI scan as part of your normal medical care
  • A parent or legal guardian is able to give written consent to participate
  • You are covered by French social security

For healthy volunteers aged 3 years and older:

  • You are between 3 and 28 years old
  • You have no known neurological (brain/nerve) or psychiatric (mental health) conditions
  • A parent or legal guardian is able to give written consent to participate
  • You are covered by French social security

For healthy volunteers under 5 years of age:

  • You are between 3 months and 5 years old
  • You have previously had an MRI scan at Necker Hospital's pediatric radiology department that came back normal
  • You have no known neurological or psychiatric conditions
  • Your legal guardian does not object to participation

Who may not be able to join:

  • You cannot have an MRI scan — for example, if you have a pacemaker, metal implants inside your body, or severe claustrophobia (fear of enclosed spaces)
  • Healthy volunteers who are unable to stay still during an MRI scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Monica ZILBOVICIUS, INSERM INSERM ERL "Trajectoires Développementales en Psychiatrie"

Phone: +33 1.71.39.65.30

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 April 2024
Est. completion
1 April 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rest cerebral blood flow (CBF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov